Search Results for: SLC4A2

4 interactions involving SLC4A2 - solute carrier family 4 member 2 found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel GET1 guided entry of tail-anchored proteins factor 1
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
ATXN1 ataxin 1
  • Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)
CA2 carbonic anhydrase 2
  • Erythrocytes take up carbon dioxide and release oxygen
  • Erythrocytes take up oxygen and release carbon dioxide
  • Reversible hydration of carbon dioxide
  • Methyclothiazide
  • Topiramate
  • Ethoxzolamide
  • Sulpiride
  • Bendroflumethiazide
  • Celecoxib
  • Benzthiazide
  • Benzthiazide
  • Valdecoxib
  • Cyclothiazide
  • Cyclothiazide
  • Furosemide
  • Methazolamide
  • Hydroflumethiazide
  • Acetazolamide
  • Dorzolamide
  • Chlorothiazide
  • Zonisamide
  • Trichlormethiazide
  • Ethinamate
  • Diazoxide
  • Diclofenamide
  • Brinzolamide
  • Quinethazone
  • p-Hydroxymercuribenzoic acid
  • N-Benzyl-4-Sulfamoyl-Benzamide
  • 4-Flourobenzenesulfonamide
  • Formic acid
  • AL5424
  • N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide
  • 3,5-Difluorobenzenesulfonamide
  • AL7089A
  • 4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide
  • Irosustat
  • 4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide
  • (R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide
  • Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide
  • AL7182
  • N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide
  • Cyanamide
  • 4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide
  • Dansylamide
  • Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester
  • N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide
  • 4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide
  • AL7099A
  • Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]
  • 2,6-Difluorobenzenesulfonamide
  • 1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide
  • (4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester
  • 4-Methylimidazole
  • AL5927
  • 1,2,4-Triazole
  • N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide
  • Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]
  • 4-Sulfonamide-[1-(4-Aminobutane)]Benzamide
  • N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide
  • AL-4623
  • Urea
  • (S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide
  • Mercuribenzoic Acid
  • 4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide
  • (4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide
  • AL5300
  • 4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide
  • 3-Mercuri-4-Aminobenzenesulfonamide
  • AL6528
  • 3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide
  • 4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide
  • 4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE
  • 4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE
  • 1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM
  • 5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE
  • 2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate
  • N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide
  • 5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide
  • THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)
  • (S)-Indapamide
  • N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE
  • (17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate
  • 5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide
  • PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE
  • N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE
  • 2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide
  • 2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide
  • N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE
  • 3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID
  • ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE
  • indane-5-sulfonamide
  • 4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE
  • N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE
  • Sulthiame
  • (9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE
  • (4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate
  • 6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE
  • 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide
  • 6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE
  • 4-(2-AMINOETHYL)BENZENESULFONAMIDE
  • Ellagic acid
  • Sodium carbonate
  • Sodium sulfate
  • Combined proximal and distal renal tubular acidosis (RTA type 3)
  • Osteopetrosis, including: Osteopetrosis, severe neonatal or infantile forms; Osteopetrosis, intermediate forms; Osteopetrosis with renal tubular acidosis; Osteopetrosis, late-onset form type 1; Osteopetrosis, late-onset form type 2; Osteopetrosis, osteoclast poor
EPB42 erythrocyte membrane protein band 4.2
  • Hereditary spherocytosis (SPH)

Page 1 out of 1 pages